Article preview from "The Gray Sheet" - December 3, 2012
The director of the Scripps Translational Science Institute talks with “The Gray Sheet” about nano sensors, the move away from medical implants, and the role that established medical device companies can play in the burgeoning digital health field.
Article preview from "The Gray Sheet" - December 3, 2012
Eric Topol, director of the Scripps Translational Science Institute in San Diego, Calif., is considered a preeminent authority on digital health. In 2009, he was named one of 12 Rock Stars of Science by GQ Magazine. Early this year, he released a book on “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care.”
A practicing cardiologist, Topol has been involved in medical technology development for more than 25 years. Several years ago, he co-founded, with the wireless technology firm Qualcomm and philanthropists Gary and Mary West, the West Wireless Health Institute, recently renamed the West Health Institute. Before that, he spent 14 years at Cleveland Clinic.
Topol is optimistic that advances in wireless health technologies and genomic medicine can help create a more efficient, less invasive and consumer-driven way to monitor chronic health conditions. He spoke with “The Gray Sheet” last week about nano sensors, the move away from medical implants, and the role that established medical device companies can play in the burgeoning digital health field.
Continued...
To read this article in its entirety, Purchase now as a PDF and receive it immediately via email. Or get it FREE when you subscribe to "The Gray Sheet".
Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512
Comments